Back
HHIF
Hejaz High Innovation Active ETF
🇦🇺 ASX
🩺 HEALTH CARE
🕊️ SOCIALLY AWARE
🤖 TECHNOLOGY
👑 Overview
📈 Performance
📙 Holdings
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
+ 3.00%
Annual Growth
1 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
1
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
HHIF.AX was created on 2024-05-02 by Hejaz . The fund's investment portfolio concentrates primarily on theme equity. To achieve a (total) return at least equal to movements in the Benchmark over a rolling 5 to 7-year timeframe through exposure to a diversified equities portfolio of Shariah Compliant listed companies poised to outperform the broader market
📈 Performance
Price History
+3.98%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →📙 Top Holdings
Show more
Eckert & Ziegler SE
12.56%
Appier Group Inc
10.19%
BYD Co Ltd Class H
9.87%
VTech Holdings Ltd
7.05%
Updated as of 30 April 2025
Industry Exposure
🤖 Information
46%
🩺 Health
33%
📙 Other
20%
💵 Costs
💼
1.55%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🍃 Environmental, Social and Governance scores ℹ️
🌳
Environmental Score
27
A measure of an organisations or investment's impact on the natural environment, including factors such as carbon emissions, resource usage, and pollution
⚖️
Governance Score
66
An evaluation of an organisations impact on society, focusing on factors such as employee welfare, diversity and inclusion, community engagement, and product safety and quality.
🤓 Advanced information
Technical Info
💰 Price*
$1.04
💰 Price To Earnings Ratio
32.95
💰 Price To Book Ratio
4.21
💰 Leveraged
No
💰 Inverse
No
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in HHIF
1
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
1 days
💵 Average investment amount
$501
⏰ Last time a customer invested in HHIF
23 days
HHIF investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
100%
Less than 50k
👶 Age of investors
18 - 25
26 - 34
100%
35 - 90
🙋 Legal gender of investors
Female
Male
100%
Pearlers who invest in HHIF also invest in...
HJZP.AX was created on 2022-10-17 by M&G . The fund's investment portfolio concentrates primarily on real estate equity. The Funds investment approach is to research, screen, and then select quality investments, across Australian and international Real Estate Investment Trusts (REITS).
📊 Share price
$0.80 AUD
🏠 REAL ESTATE
ISLM.AX was created on 2020-10-17 by Hejaz . The fund's investment portfolio concentrates primarily on total market equity. To achieve a (total) return at least equal to movements- in the Benchmark over rolling 5 to 7 year timeframe through exposure to a diversified equities portfolio of shariah Compliant investments.
📊 Share price
$1.14 AUD
🧱 MATERIALS
HJHI.AX was created on 2024-05-02 by Hejaz . The fund's investment portfolio concentrates primarily on total market equity. To achieve a (total) return at least equal to movements in the Benchmark over a rolling 5 to 7-year timeframe through exposure to a diversified portfolio of Shariah Compliant listed companies with a proven history of significant dividends and a market capitalisation exceeding $2 billion.
📊 Share price
$1.06 AUD
🛍️ CONSUMER
🏭 INDUSTRIALS
Want more shares? Try these...
Health House International Ltd. is an international distributor of medicinal cannabis. The company is headquartered in Perth, Western Australia. The company went IPO on 2011-07-28. The company is specialized importer, exporter, consolidator and distributor of medicinal cannabis products. The firm distributes medicinal cannabis products to pharmacies, prescribers, specialist medicinal cannabis clinics and researchers across Australasia. The company supplies pharmacies, hospital, government departments, veterinarians and other wholesalers with medicinal cannabis and general pharmaceutical products across the United Kingdom and Europe. The products distributed by the Company include iX Biopharma’s Xativa, which is formulated using WaferiX, which is sublingual delivery technology, and Zelira Therapeutics’ cannabinoid-based customized medicines, including HOPE1, HOPE2 and Zenivol oil blended with pharmaceutical-grade sunflower oil. The company distributes Levin Health’s cannabinoid-based, chronic pain medicines, such as LEVIN CBD 100 and LEVIN Balance 10:12.
📊 Share price
🕊️
Social Score
99
An assessment of an organisations management practices, board structure, transparency, and accountability, reflecting its commitment to ethical behavior and responsible decision-making.